Rep. Brad Wenstrup @RepBradWenstrup
Therapeutics must continue to be a critical component of our COVID-19 response. We’ve seen a lot of promise with treating individuals with monoclonal antibodies, and this news from Merck appears to be another positive development. https://t.co/OLfmn9CPgb — PolitiTweet.org